Found: 31
Select item for more details and to access through your institution.
Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1506, doi. 10.1111/dom.13675
- By:
- Publication type:
- Article
Body mass index and insulin use as identifiers of high‐cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1419, doi. 10.1111/dom.13671
- By:
- Publication type:
- Article
Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1455, doi. 10.1111/dom.13680
- By:
- Publication type:
- Article
Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre‐specified analysis of the Chinese population from the BERSON clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1464, doi. 10.1111/dom.13700
- By:
- Publication type:
- Article
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1474, doi. 10.1111/dom.13681
- By:
- Publication type:
- Article
Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1445, doi. 10.1111/dom.13679
- By:
- Publication type:
- Article
Role of vagal activation in postprandial glucose metabolism after gastric bypass in individuals with and without hypoglycaemia.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1513, doi. 10.1111/dom.13676
- By:
- Publication type:
- Article
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1437, doi. 10.1111/dom.13677
- By:
- Publication type:
- Article
Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1502, doi. 10.1111/dom.13674
- By:
- Publication type:
- Article
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1429, doi. 10.1111/dom.13673
- By:
- Publication type:
- Article
Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non‐surgical and bariatric surgery patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1498, doi. 10.1111/dom.13672
- By:
- Publication type:
- Article
Uric acid and the cardio‐renal effects of SGLT2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1291, doi. 10.1111/dom.13670
- By:
- Publication type:
- Article
Effect of cilostazol, a phosphodiesterase‐3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes: ESCAPE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1409, doi. 10.1111/dom.13667
- By:
- Publication type:
- Article
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1493, doi. 10.1111/dom.13668
- By:
- Publication type:
- Article
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1399, doi. 10.1111/dom.13666
- By:
- Publication type:
- Article
Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1381, doi. 10.1111/dom.13664
- By:
- Publication type:
- Article
Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1388, doi. 10.1111/dom.13665
- By:
- Publication type:
- Article
Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non‐insulin antidiabetic drugs in a real‐world setting.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1373, doi. 10.1111/dom.13663
- By:
- Publication type:
- Article
Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1349, doi. 10.1111/dom.13660
- By:
- Publication type:
- Article
Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1365, doi. 10.1111/dom.13662
- By:
- Publication type:
- Article
Intranasal glucagon acutely increases energy expenditure without inducing hyperglycaemia in overweight/obese adults.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1357, doi. 10.1111/dom.13661
- By:
- Publication type:
- Article
Weight loss in patients with type 2 diabetes receiving once‐weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post‐hoc analysis of the AWARD‐4 study across baseline body mass index subgroups.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1340, doi. 10.1111/dom.13658
- By:
- Publication type:
- Article
Association between allopurinol and cardiovascular outcomes and all‐cause mortality in diabetes: A retrospective, population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1322, doi. 10.1111/dom.13656
- By:
- Publication type:
- Article
Direct medical costs in the preceding, event and subsequent years of a first severe hypoglycaemia episode requiring hospitalization: A population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1330, doi. 10.1111/dom.13657
- By:
- Publication type:
- Article
Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1487, doi. 10.1111/dom.13655
- By:
- Publication type:
- Article
When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1305, doi. 10.1111/dom.13653
- By:
- Publication type:
- Article
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1311, doi. 10.1111/dom.13654
- By:
- Publication type:
- Article
Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1277, doi. 10.1111/dom.13652
- By:
- Publication type:
- Article
Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1299, doi. 10.1111/dom.13649
- By:
- Publication type:
- Article
Oral amoxicillin‐clavulanate for treating diabetic foot infections.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1483, doi. 10.1111/dom.13651
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1275, doi. 10.1111/dom.13430
- Publication type:
- Article